LA JOLLA, Calif.--(BUSINESS WIRE)--The California Healthcare Institute (CHI) today issued the white paper “Impact of Patent Law Changes on Biomedical Investment and Innovation.” The paper analyzes several recent developments related to patent law that could have serious implications to the biomedical industry in California and nationwide. These include: (1) recent U.S. Supreme Court decisions that weaken patents; (2) patent reform legislation being considered by Congress; and (3) the hostile approach taken by the U.S. Patent and Trademark Office (USPTO) toward making and promulgating new patent rules.
